spacer
home > ict > Summer 2019
PUBLICATIONS

International Clinical Trials

ict
Summer 2019

   
Text
PDF
bullet
End Point
End Point

Then and Now

ICT’s Editor, Dr Graham Hughes, looks back to 1959 and examines the differences in the pharmaceutical industry between then and now, as well as how much further we have to go.
 
view
download pdf
bullet
Features
Patient Centricity in the Product Lifecycle

The Patient Journey

For Susan Najjar at Sciformix, a Covance company, it is essential to develop business strategies that are centred on the patient to allow them a greater control over their own treatment.
 
view
download pdf
Q&A: Selecting Your CRO

Finding the Right Fit

There are many factors to consider when choosing your CRO, and Catherine Konidas at Altasciences speaks with ICT to help guide you through this critical process.
 
view
download pdf
Spotlight

Moving in a New Direction

Clinical Trials Europe will be taking place in Barcelona, Spain, and Louisa Maitland at KNect365 speaks with ICT about the changes to the scope of the conference, with a new and broader focus.
 
view
download pdf
Enrolment Planning Technology

Plan, Track, and Refine

Enrolment planning technology will help optimise strategies and meet milestones, maintaining the long-term health of your clinical trials, argues Mark Springer at IQVIA Technologies.
 
view
download pdf
Q&A: Remote Data Collection

Therapeutic Oncology and the Road Ahead

The world is changing, as are the means of capturing and compiling outcomes data. Dr Tim Williams at My Clinical Outcomes answers questions from ICT about the current and future trends in therapeutic oncology.
 
view
download pdf
bullet
Regulatory Affairs
Improving the Chances of FDA Approval

Expert Tips for a Successful Application

Dr Harneet Arora at Kolabtree provides guidance in the nervewracking process of submitting a drug for FDA review, from organising your paperwork to a better presentation of evidence.
 
view
download pdf
Cell Therapy Starting Materials

The Landscape of Clinical Approval

HemaCare's Dominic Clarke and Brad N Taylor expand on the FDA and EMA's attempts to accelerate cell therapy drug approvals under the new Regenerative Medicine Advanced Therapy designation.
 
view
download pdf
Clinical Trial Application Processes

Outsourcing Trial Applications

Paul Carrodus at TMC Pharma Services explains why regulatory guidance and legislation can have significant implications when outsourcing applications to EU competent authorities.
 
view
download pdf
bullet
Pharmacovigilance
Pharmacovigilance Outsourcing

The Long and Short of CRO Selection

PharSafer’s Graeme Ladds assesses the responsibilities of sponsors and licence holders for pharmacovigilance outsourcing, and how knowledge, geography, and scope are all important factors in the decision process.
 
view
download pdf
Pharmacovigilance and GDPR

Post-Marketing Pharmacovigilance

From European legislation to GDPR compliance, Emma Boulton and Dora Amene at PIPA analyse the importance of data protection in pharmacovigilance systems.
 
view
download pdf
bullet
Regional Focus: South East Asia
Clinical Trials in Asia Pacific

The Pacific Century

With an expanding economic and regulatory landscape, the clinical trials industry in the Asia Pacific is booming. CIDP Singapore’s Bandana Seesurn explores the reasons behind this growth.
 
view
download pdf
bullet
Clinical Trials and Social Media
Healthcare and Social Media

Transforming Clinical Trials

CREATION’s Jamie Doggett describes how the increasing use of social media and online platforms by healthcare professionals can ensure improved access and aid in clinical trial recruitment.
 
view
download pdf
Social Media in Clinical Research

Patient Recruitment in the Digital Age

Social media has opened up a world of possibilities for patient recruitment in clinical trials, explain Miaesha Campbell and Amanda Siegert at Medpace.
 
view
download pdf
bullet
FSP Versus Full Service
The Benefits of a Functional Service Provider

The Service Model Dichotomy

 
Quanticate’s Daniel Chapple highlights the differences between full-service models and functional service provision to help trial sponsors find the optimal solution for supporting clinical development.
 
view
download pdf
Sustainable Service Provision

Choosing a Winning Model

From uncapped time and materials to fixed fee approaches, Jo Marshall at CROS NT outlines the four basic service models and how best to achieve ‘sustained quality’.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Automated Enzyme Analyzers Streamline Enzyme Assay Applications

SUNNYVALE, Calif. – (September 16, 2021) – Multi-enzyme analysis can now be achieved through a single, fully-automated enzyme analyzer, benefitting industrial enzyme manufacturers and enzyme users in the food, beverage, biopharmaceutical, fuel ethanol and chemical, and solid waste management industries.
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement